$EXPO
EXPONENT INC

2024 Q1 Form 10-K Financial Statement

#000095017024019390 Filed on February 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $144.9M $122.9M $536.8M
YoY Change 3.3% -3.5% 4.57%
Cost Of Revenue $7.726M $9.028M $39.58M
YoY Change -33.42% -38.86% -20.0%
Gross Profit $137.2M $113.9M $497.2M
YoY Change 6.61% 1.14% 7.19%
Gross Profit Margin 94.67% 92.65% 92.63%
Selling, General & Admin $95.96M $84.80M $344.3M
YoY Change 6.6% 2.15% 16.74%
% of Gross Profit 69.94% 74.47% 69.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.324M $2.416M $8.916M
YoY Change 16.9% 30.24% 25.95%
% of Gross Profit 1.69% 2.12% 1.79%
Operating Expenses $106.5M $95.48M $385.9M
YoY Change -4.22% 5.44% 3.6%
Operating Profit $30.71M $18.39M $111.3M
YoY Change 5.47% -16.52% -20.96%
Interest Expense $2.626M $1.929M $7.150M
YoY Change 48.36% 52.85% -161.8%
% of Operating Profit 8.55% 10.49% 6.42%
Other Income/Expense, Net $7.084M $9.765M $17.42M
YoY Change 10.38% 35.21% -262.78%
Pretax Income $40.42M $30.09M $135.9M
YoY Change 13.75% -1.41% 2.77%
Income Tax $10.28M $9.159M $35.56M
% Of Pretax Income 25.43% 30.44% 26.16%
Net Earnings $30.14M $20.93M $100.3M
YoY Change 3.5% -7.08% -1.95%
Net Earnings / Revenue 20.8% 17.03% 18.69%
Basic Earnings Per Share $0.59 $1.96
Diluted Earnings Per Share $0.59 $0.41 $1.94
COMMON SHARES
Basic Shares Outstanding 50.56M 50.62M 51.15M
Diluted Shares Outstanding 51.42M 51.64M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $168.7M $187.2M $187.2M
YoY Change 34.24% 15.91% 15.91%
Cash & Equivalents $168.7M $187.2M $54.69M
Short-Term Investments
Other Short-Term Assets $20.77M $25.02M $25.02M
YoY Change 6.05% 42.29% 42.29%
Inventory
Prepaid Expenses
Receivables $162.9M $167.4M $167.4M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $352.3M $379.5M $379.5M
YoY Change 10.69% 8.7% 8.7%
LONG-TERM ASSETS
Property, Plant & Equipment $74.50M $75.32M $99.92M
YoY Change 7.33% 14.92% 19.6%
Goodwill $8.607M $8.607M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.759M $3.727M $158.7M
YoY Change 62.59% 85.79% 9.2%
Total Long-Term Assets $277.1M $267.2M $267.2M
YoY Change 11.67% 12.52% 12.52%
TOTAL ASSETS
Total Short-Term Assets $352.3M $379.5M $379.5M
Total Long-Term Assets $277.1M $267.2M $267.2M
Total Assets $629.4M $646.8M $646.8M
YoY Change 11.12% 10.25% 10.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.93M $4.489M $4.489M
YoY Change -9.1% -48.06% -48.06%
Accrued Expenses $74.10M $17.64M $135.7M
YoY Change 8.51% -13.86% 3.16%
Deferred Revenue $16.11M $21.71M
YoY Change 10.56% 15.26%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $114.1M $161.9M $161.9M
YoY Change 4.54% 1.81% 1.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.580M $3.426M $128.8M
YoY Change 42.46% 45.48% 20.49%
Total Long-Term Liabilities $3.580M $3.426M $128.8M
YoY Change 42.46% 45.48% 20.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.1M $161.9M $161.9M
Total Long-Term Liabilities $3.580M $3.426M $128.8M
Total Liabilities $255.1M $290.7M $290.7M
YoY Change 13.59% 9.32% 9.32%
SHAREHOLDERS EQUITY
Retained Earnings $588.6M $574.1M
YoY Change 8.4% 8.56%
Common Stock $335.1M $321.5M
YoY Change 6.52% 6.79%
Preferred Stock
YoY Change
Treasury Stock (at cost) $546.2M $536.5M
YoY Change 6.55% 6.13%
Treasury Stock Shares
Shareholders Equity $374.3M $356.1M $356.1M
YoY Change
Total Liabilities & Shareholders Equity $629.4M $646.8M $646.8M
YoY Change 11.12% 10.25% 10.25%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $30.14M $20.93M $100.3M
YoY Change 3.5% -7.08% -1.95%
Depreciation, Depletion And Amortization $2.324M $2.416M $8.916M
YoY Change 16.9% 30.24% 25.95%
Cash From Operating Activities $10.43M $71.35M $127.4M
YoY Change -255.63% 75.87% 35.76%
INVESTING ACTIVITIES
Capital Expenditures $1.482M $1.956M $16.36M
YoY Change -73.85% -33.36% 35.81%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$1.482M -$1.956M -$16.36M
YoY Change -73.85% -33.36% 35.81%
FINANCING ACTIVITIES
Cash Dividend Paid $15.58M $54.04M
YoY Change 7.47% 9.76%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -27.23M -20.01M -86.01M
YoY Change 14.69% -21.29% -60.18%
NET CHANGE
Cash From Operating Activities 10.43M 71.35M 127.4M
Cash From Investing Activities -1.482M -1.956M -16.36M
Cash From Financing Activities -27.23M -20.01M -86.01M
Net Change In Cash -18.49M 49.39M 25.69M
YoY Change -48.38% 304.35% -118.86%
FREE CASH FLOW
Cash From Operating Activities $10.43M $71.35M $127.4M
Capital Expenditures $1.482M $1.956M $16.36M
Free Cash Flow $8.950M $69.40M $111.0M
YoY Change -172.35% 84.39% 35.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000851520
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-29
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-29
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
0-18655
CY2023 dei Entity Registrant Name
EntityRegistrantName
EXPONENT, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0218904
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
149 Commonwealth Drive
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Menlo Park
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
CY2023 dei City Area Code
CityAreaCode
650
CY2023 dei Local Phone Number
LocalPhoneNumber
326-9400
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023 dei Trading Symbol
TradingSymbol
EXPO
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
3400000000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50563193
CY2023 dei Auditor Name
AuditorName
KPMG, LLP
CY2023 dei Auditor Location
AuditorLocation
San Francisco, California
CY2023 dei Auditor Firm
AuditorFirmId
185
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
497189000
CY2022 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
463820000
CY2021 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
434850000
CY2023 expo Revenue From Reimbursement
RevenueFromReimbursement
39577000
CY2022 expo Revenue From Reimbursement
RevenueFromReimbursement
49473000
CY2021 expo Revenue From Reimbursement
RevenueFromReimbursement
31419000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
536766000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
513293000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
466269000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
319886000
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
264235000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
278047000
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
41541000
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
35083000
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
32594000
CY2023 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
39577000
CY2022 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
49473000
CY2021 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
31419000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24440000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23660000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15282000
CY2023 us-gaap Operating Expenses
OperatingExpenses
425444000
CY2022 us-gaap Operating Expenses
OperatingExpenses
372451000
CY2021 us-gaap Operating Expenses
OperatingExpenses
357342000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
111322000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
140842000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
108927000
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
7150000
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
2096000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
66000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17424000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10704000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16844000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
135896000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
132234000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
125837000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35557000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29904000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24635000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
100339000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
102330000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
101202000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.96
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.98
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.92
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.94
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.9
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51152000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51727000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52610000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51635000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52280000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53331000
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.04
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.96
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.8
CY2023 us-gaap Net Income Loss
NetIncomeLoss
100339000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
102330000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
101202000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
610000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1604000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
14000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
100949000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
100726000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
101151000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187150000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161458000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5281000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6193000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
167360000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170114000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25022000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17585000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
349157000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75318000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65539000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
379532000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24600000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18007000
CY2023Q4 us-gaap Goodwill
Goodwill
8607000
CY2022Q4 us-gaap Goodwill
Goodwill
8607000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53824000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
53909000
CY2023Q4 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
101169000
CY2022Q4 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
89437000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3727000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2006000
CY2023Q4 us-gaap Assets
Assets
646777000
CY2022Q4 us-gaap Assets
Assets
586662000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
22125000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
29115000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
111773000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105822000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21709000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18834000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6302000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5258000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
161909000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
159029000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3426000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2355000
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
103398000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
91183000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21959000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13343000
CY2023Q4 us-gaap Liabilities
Liabilities
290692000
CY2022Q4 us-gaap Liabilities
Liabilities
265910000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
66000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
66000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
321448000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
301002000
CY2021 us-gaap Profit Loss
ProfitLoss
101202000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2977000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3587000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
574082000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
528810000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15134000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15064000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
536534000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
505539000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
356085000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
320752000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
646777000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
586662000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
361498000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1977000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1134000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9296000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7000000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7637000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15666000
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-6000
CY2021 us-gaap Dividends
Dividends
43021000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
101202000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2020000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9999000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
155856000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1604000
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10200000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-12904000
CY2022 us-gaap Dividends
Dividends
50498000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
102330000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
320752000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2084000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
100000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9912000
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24208000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
610000
CY2023 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10496000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-9942000
CY2023 us-gaap Dividends
Dividends
54058000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
100339000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
356085000
CY2023 us-gaap Profit Loss
ProfitLoss
100339000
CY2022 us-gaap Profit Loss
ProfitLoss
102330000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8916000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7079000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6487000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
11000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3225000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3081000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1958000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
20357000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
20364000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19263000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
85000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7363000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6005000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
471000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33334000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30254000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6669000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6124000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4407000
CY2023 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
152000
CY2022 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
7000
CY2021 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
406000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5055000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2215000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8443000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3902000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6494000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
20336000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2875000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-928000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7962000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127352000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
93807000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124568000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16356000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12043000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6826000
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
34994000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
79998000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16356000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12043000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38178000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9942000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12904000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15666000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
24208000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
155856000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7000000
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2184000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2020000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3111000
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
54043000
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
49237000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
43198000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-86009000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-215977000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-62753000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
705000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2016000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
169000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25692000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-136229000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
100162000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161458000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297687000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197525000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187150000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161458000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297687000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Estimates are used for, but not limited to, revenue recognition, allowance for contract losses and doubtful accounts, stock-based compensation, income taxes, goodwill, the useful life of property, equipment and leasehold improvements, and operating lease liabilities. Actual results could differ from those estimates.</span></p>
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51152000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51727000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52610000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51635000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52280000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53331000
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
59459
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
14463000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
15384000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8387000
CY2023 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
12268000
CY2022 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
28754000
CY2021 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
15357000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
169873000
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
116564000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
10353000
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
116564000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
152890000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
101354000
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
101354000
CY2023Q4 us-gaap Land
Land
18339000
CY2022Q4 us-gaap Land
Land
18339000
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
69698000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
69600000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1114000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1381000
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
54008000
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
54476000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
12411000
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10632000
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
23759000
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
14145000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
179329000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
168573000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
104011000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
103034000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75318000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65539000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8916000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7079000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6487000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5281000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6193000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
167360000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170114000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4489000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8642000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17636000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20473000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
22125000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
29115000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
68415000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
67805000
CY2023Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
11138000
CY2022Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
9812000
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
13492000
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
13106000
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
13166000
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
10171000
CY2023Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
5562000
CY2022Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
4928000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
111773000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
105822000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
10646000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
12326000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
23193000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
24411000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
19800000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2254000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1973000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2252000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10025000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10883000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8588000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
35472000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
37267000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
30640000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-775000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4910000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3930000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
860000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2453000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2075000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
85000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7363000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6005000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35557000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29904000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24635000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
28538000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
27769000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
26426000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
8587000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
6726000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
5174000
CY2023 expo Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation
IncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation
870000
CY2022 expo Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation
IncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation
1160000
CY2021 expo Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation
IncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensation
997000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
456000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
52000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
19000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
12000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
12000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
13000
CY2023 expo Income Tax Reconciliation Excess Tax Benefit From Share Based Compensation
IncomeTaxReconciliationExcessTaxBenefitFromShareBasedCompensation
2844000
CY2022 expo Income Tax Reconciliation Excess Tax Benefit From Share Based Compensation
IncomeTaxReconciliationExcessTaxBenefitFromShareBasedCompensation
4533000
CY2021 expo Income Tax Reconciliation Excess Tax Benefit From Share Based Compensation
IncomeTaxReconciliationExcessTaxBenefitFromShareBasedCompensation
7850000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-264000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-693000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-622000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
202000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-589000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
478000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35557000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29904000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24635000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.262
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.226
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
21235000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
20740000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
40280000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
36819000
CY2023Q4 expo Deferred Tax Assets Operating Leases
DeferredTaxAssetsOperatingLeases
7853000
CY2022Q4 expo Deferred Tax Assets Operating Leases
DeferredTaxAssetsOperatingLeases
5386000
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
453000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
212000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
88000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
69368000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
63698000
CY2023Q4 expo Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
2255000
CY2022Q4 expo Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
2265000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
2071000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
2138000
CY2023Q4 expo Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
7853000
CY2022Q4 expo Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
5386000
CY2023Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
1652000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1695000
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
18000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
15544000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
9789000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
53824000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
53909000
CY2023 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
3620000
CY2022 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
5829000
CY2021 expo Total Excess Tax Benefit From Share Based Compensation
TotalExcessTaxBenefitFromShareBasedCompensation
10009000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1949000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
630000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
532000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2047000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
571000
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
473000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2145000
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1695000
CY2023 expo Unrecognized Liability For Uncertain Tax Positions For Next Twelve Months
UnrecognizedLiabilityForUncertainTaxPositionsForNextTwelveMonths
0
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13169000
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
CY2023Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13217000
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
CY2023Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13177000
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
CY2023Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13148000
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
52711000
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.24
CY2022Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12383000
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.24
CY2022Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12345000
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.24
CY2022Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12225000
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.24
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12153000
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
49106000
CY2023 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
1009000
CY2022 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
1392000
CY2021 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
1679000
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
288000
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
24208000
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1756000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
155856000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
78000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7000000
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
45000000
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
38390000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
25277000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
29875000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
31984000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
99.47
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
94.24
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
97.8
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
441227
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
47.38
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
107.31
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7992
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.51
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
463235
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
51.86
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M10D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17543000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
378444
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
42.19
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y14D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
17453000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
742000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4335000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
38.29
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
26.64
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.32
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
20357000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
20364000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19263000
CY2023 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
3620000
CY2022 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
5829000
CY2021 expo Income Tax Benefit Associated With Stockbased Compensation
IncomeTaxBenefitAssociatedWithStockbasedCompensation
10009000
CY2023 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2023 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2023 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2023 expo Defined Contribution Plan Employer Contribution Annual Vesting Percentage
DefinedContributionPlanEmployerContributionAnnualVestingPercentage
0.20
CY2023 expo Defined Contribution Plan Employer Contribution Annual Vesting Period
DefinedContributionPlanEmployerContributionAnnualVestingPeriod
P5Y
CY2023 expo Defined Contribution Plan Employer Contribution Percentage Of Eligible Wages
DefinedContributionPlanEmployerContributionPercentageOfEligibleWages
0.07
CY2023 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
11867000
CY2022 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
10166000
CY2021 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
9923000
CY2023Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
115187000
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
100731000
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
116564000
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
101354000
CY2023 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
14315000
CY2022 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-14187000
CY2021 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
14730000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
7249000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
6564000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
6962000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.043
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7260000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6380000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5734000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4446000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1868000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
8247000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33935000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5674000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
28261000
CY2023 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
3371000
CY2022 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
2938000
CY2021 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
2658000
CY2023 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
14315000
CY2022 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
-14187000
CY2021 expo Gain Loss On Deferred Compensation Investments
GainLossOnDeferredCompensationInvestments
14730000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-259000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
522000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-517000
CY2023 expo Other Miscellaneous Income Loss Net
OtherMiscellaneousIncomeLossNet
-3000
CY2022 expo Other Miscellaneous Income Loss Net
OtherMiscellaneousIncomeLossNet
23000
CY2021 expo Other Miscellaneous Income Loss Net
OtherMiscellaneousIncomeLossNet
-27000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17424000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10704000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16844000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
38944000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
40121000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
27912000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
CY2023 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10496000
CY2022 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10200000
CY2021 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7637000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
15749000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9476000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
792000
CY2023 expo Leasehold Improvements Obtained In Exchange For Right Of Use Asset
LeaseholdImprovementsObtainedInExchangeForRightOfUseAsset
3219000
CY2022 expo Leasehold Improvements Obtained In Exchange For Right Of Use Asset
LeaseholdImprovementsObtainedInExchangeForRightOfUseAsset
0
CY2021 expo Leasehold Improvements Obtained In Exchange For Right Of Use Asset
LeaseholdImprovementsObtainedInExchangeForRightOfUseAsset
0
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
137000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1017000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
413000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
536766000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
513293000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
466269000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
111322000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
140842000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
108927000
CY2023 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
18695000
CY2022 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
12647000
CY2021 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
6637000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8916000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7079000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6487000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75318000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
65539000
CY2023 us-gaap Revenues
Revenues
536766000
CY2022 us-gaap Revenues
Revenues
513293000
CY2021 us-gaap Revenues
Revenues
466269000
CY2023Q4 us-gaap Goodwill
Goodwill
8607000
CY2022Q4 us-gaap Goodwill
Goodwill
8607000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2022 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2021 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0

Files In Submission

Name View Source Status
0000950170-24-019390-index-headers.html Edgar Link pending
0000950170-24-019390-index.html Edgar Link pending
0000950170-24-019390.txt Edgar Link pending
0000950170-24-019390-xbrl.zip Edgar Link pending
expo-20231229.htm Edgar Link pending
expo-20231229.xsd Edgar Link pending
expo-ex21_1.htm Edgar Link pending
expo-ex23_1.htm Edgar Link pending
expo-ex31_1.htm Edgar Link pending
expo-ex31_2.htm Edgar Link pending
expo-ex32_1.htm Edgar Link pending
expo-ex32_2.htm Edgar Link pending
expo-ex3_1ii.htm Edgar Link pending
expo-ex97_0.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img37928738_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
expo-20231229_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending